Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9446| Title: | Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial | Authors: | Chan, Arlene Moy, Beverly Mansi, Janine Ejlertsen, Bent Holmes, Frankie Ann Chia, Stephen Iwata, Hiroji Gnant, Michael Loibl, Sibylle Barrios, Carlos H. Somali, Isil Smichkoska, Snezhana Martinez, Noelia Alonso, Mirta Garcia Link, John S. Mayer, Ingrid A. Cold, Søren Murillo, Serafin Morales Senecal, Francis Inoue, Kenichi Ruiz-Borrego, Manuel Hui, Rina Denduliri, Neelima Patt, Debra Rugo, Hope S. Johnston, Stephen R.D. Bryce, Richard Zhang, Bo Xu, Feng Wong, Alvin Martin, Miguel |
Issue Date: | Oct-2020 | Publisher: | Elsevier BV | Journal: | Clinical Breast Cancer | URI: | http://hdl.handle.net/20.500.12188/9446 | DOI: | 10.1016/j.clbc.2020.09.014 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.